Market Analysis
Is Palantir Proving to be the Dark Horse AI Stock?
Palantir is no ordinary company. But a supplier of new governance technology, with a first mover advantage.
Total Stories
2,801
News
Market Analysis
Section
Market Analysis
Market Analysis
AMD Hits 52-Week Low as AI Growth and Outlook Disappoints Analysts
AMD's stock dropped over 10% after Citi downgraded its rating due to concerns about slowing AI growth.
Market Analysis
Uber’s Expected Revenue Growth of 18.3% Signals Strong Q4 Performance
Uber is set to announce its fourth-quarter earnings with expectations of an 18.3% year-on-year revenue growth.
Market Analysis
PayPal Announces $15 Billion Share Buyback Amidst 9% Stock Decline
PayPal exceeded fourth-quarter financial expectations but faced a share decline due to concerns over slowing card processing growth.
Market Analysis
Constellation Brands Downgraded Amid U.S.-Canada Trade Dispute
Ontario retaliates against U.S. tariffs by removing American alcohol products from its shelves.
International
Tradewar Guidebook: What Should Retail Investors Expect?
Automakers and fuel exporters should expect impact. But the US is in a stronger position to impose protectionism.
Market Analysis
Auto Stocks Decline on Tariff News; Ford Sees Hope in Domestic Production
The new US tariff policy framework has caused significant stock declines and strategic shifts in the automotive industry.
Market Analysis
Exxon vs. Chevron: Which is the Better Dividend Aristocrat?
No bad choice between dividend aristocrat stocks. But ExxonMobil is stronger for greater expansion.
Market Analysis
Bitcoin Dips to $95,816 as Trump’s Trade War Influences Crypto Markets
Bitcoin's value drops below $100,000 amid geopolitical tensions, tariff impacts, and trading fluctuations.
Market Analysis
Apple Stock Gains as Services Drive Earnings, Calming iPhone Slowdown Fears
Apple's first-quarter 2025 financial results set new records with $124.3 billion in revenue, driven by a strong services segment.
Market Analysis
Vertex Pharmaceuticals Stock Soars as Non-Opioid Pain Treatment Gets FDA Nod
Vertex Pharmaceuticals' newly FDA-approved non-opioid analgesic, Journavx, offers a groundbreaking alternative for managing acute pain.
Market Analysis
Bitcoin Hits $105,820.58 Amidst Growing Institutional Adoption, Texas Seeks BTC Reserve
Bitcoin's price surge to $105,820.58 and its increasing integration into traditional financial systems.
Market Analysis
IBM Projects a 5% Revenue Growth for 2025 Amid AI and Cloud Success
IBM's strong fourth-quarter results were driven by significant growth in its software division.